Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fibrosarcoma of bone].

S André, B Tomeno, M Forest

    Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Fibrosarcoma of bone is a rare bone tumor, accounting for 10% of all bone tumors. Survival rates are low, with only 40% of patients surviving five years post-treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevascular mediastinal angyomiolipoma. A case report.

    Pulmonology·2023
    Same author

    Characterization of lymphocyte profiles in children with syndromic obesity.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2023
    Same author

    [Roles and impacts of pharmaceutical activity from 1990 to today: Literature review and research perspectives].

    Annales pharmaceutiques francaises·2019
    Same author

    COPD and Cardiovascular Disease.

    Pulmonology·2018
    Same author

    Prevalence of late-onset pompe disease in Portuguese patients with diaphragmatic paralysis - DIPPER study.

    Revista portuguesa de pneumologia·2017
    Same author

    [An experimental study of bioglass implants in bone].

    International orthopaedics·2016

    Area of Science:

    • Oncology
    • Orthopedic Surgery
    • Pathology

    Background:

    • Fibrosarcoma of bone is a rare malignant bone tumor.
    • Accurate diagnosis can be challenging due to microscopic similarities with other spindle cell lesions.

    Purpose of the Study:

    • To analyze the clinical outcomes and treatment efficacy for fibrosarcoma of bone.
    • To identify prognostic factors influencing patient survival.

    Main Methods:

    • Retrospective analysis of 45 cases of fibrosarcoma of bone treated between 1949 and 1979.
    • Exclusion of tumors with chondrogenesis or osteogenesis.
    • Evaluation of treatment modalities including amputation, resection, and irradiation.

    Main Results:

    Related Experiment Videos

  • Fibrosarcoma constituted 10% of all bone tumors studied.
  • Five-year survival rate was 40% globally.
  • Amputation yielded a 5-year survival rate of 68% (15/22 patients).
  • Irradiation alone had poor outcomes, with only 30% survival after high dosage.
  • Tumor location (proximal) and patient age (>40 years) were associated with poorer prognosis.

    • Conclusions:

    • Fibrosarcoma of bone has a poor prognosis, with limited survival rates.
    • Amputation appears to be a more effective treatment than irradiation alone.
    • Age and tumor location significantly impact survival, highlighting the need for individualized treatment strategies.